Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy

2020/03/27 by Ning Tang, Huan Bai, Xing Chen +3 · 4 citations
Medicine · #COVID-19 Clinical Research Studies #Heparin-Induced Thrombocytopenia and Thrombosis #Retinal and Optic Conditions

paper · pdf · doi:10.1111/jth.14817

openalex publication_date 2020/03/27 · crossref created 2020/03/27 · crossref issued 2020/05/01 · crossref published 2020/05/01 · crossref published-print 2020/05/01 · openalex created_date 2025/10/10 · crossref deposited 2025/10/27 · crossref indexed 2026/07/29 · openalex updated_date 2026/07/29

Citations

• Coagulation and sepsis
• Platelet “first responders” in wound response, cancer, and metastasis
• Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
• Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
• Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
• The Biology of Lactoferrin, an Iron-Binding Protein That Can Help Defend Against Viruses and Bacteria

Cited by

• Anticipating and managing coagulopathy and thrombotic manifestations of severe COVID-19
• Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
• Can nebulised heparin reduce acute lung injury in patients with SARS‑CoV‑2 requiring advanced respiratory support in Ireland: the CHARTER‑Ireland phase Ib/IIa, randomised, parallel-group, open-label study
• Complement activation and endothelial perturbation parallel COVID-19 severity and activity